METHOD FOR CULTURING PRIMARY CELLS OF GASTRIC CANCER AND GALLBLADDER AND BILE DUCT CANCER, AND SUPPORTING REAGENTS

(19)

(11)

EP 3 954 764 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	30.04.2025 Bulletin 2025/18

(45)	Mention of the grant of the patent:
	19.02.2025 Bulletin 2025/08

(21)	Application number: 19924173.8

(22)	Date of filing: 04.11.2019

(51)

International Patent Classification (IPC):

C12N 5/09^(2010.01)

C12Q 1/02^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	C12N 5/0693; C12N 5/0679; C12N 2501/11; C12N 2501/12; C12N 2500/32; C12N 2500/25; C12N 2501/119; C12N 2501/415; C12N 2501/727; C12N 2501/734

(86)	International application number:
	PCT/CN2019/115306

(87)	International publication number:
	WO 2020/206999 (15.10.2020 Gazette 2020/42)

(54)

METHOD FOR CULTURING PRIMARY CELLS OF GASTRIC CANCER AND GALLBLADDER AND BILE DUCT CANCER, AND SUPPORTING REAGENTS

VERFAHREN ZUR ZÜCHTUNG VON PRIMÄRZELLEN VON MAGENKREBS UND GALLENBLASEN- UND GALLENGANGSKREBS UND UNTERSTÜTZENDE REAGENZIEN

PROCÉDÉ DE CULTURE DE CELLULES PRIMAIRES DE CANCER GASTRIQUE ET DE CANCER DE LA VÉSICULE BILIAIRE ET DE CANAL CHOLÉDOQUE, ET RÉACTIFS DE SUPPORT

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

11.04.2019 CN 201910289073
11.04.2019 CN 201910289074

(43)	Date of publication of application:
	16.02.2022 Bulletin 2022/07

(73)	Proprietor: GeneX Health Co., Ltd
	Beijing 100195 (CN)

(72)	Inventors:
	YIN, Shenyi Beijing 101105 (CN) ZHANG, Hanshuo Beijing 101105 (CN)

(74)	Representative: Isarpatent
	Patent- und Rechtsanwälte Barth Charles Hassa Peckmann & Partner mbB Friedrichstrasse 31 80801 München 80801 München (DE)

(56)

References cited: :

WO-A1-2018/096881
CN-A- 103 966 168
CN-A- 104 560 878
CN-A- 108 624 561
US-A1- 2014 243 227

CN-A- 103 194 429
CN-A- 104 403 996
CN-A- 105 229 150
US-A1- 2012 164 732

GEORGIOS VLACHOGIANNIS ET AL: "Patient-derived organoids model treatment response of metastatic gastrointestinal cancers", SCIENCE, vol. 359, no. 6378, 23 February 2018 (2018-02-23), US, pages 920 - 926, XP055596283, ISSN: 0036-8075, DOI: 10.1126/science.aao2774

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).